NF-κB is a transcription factor that is associated with inflammatory responses, Withaferin A treatment has been observed to inhibit NF-κB, suppress the nuclear translocation of its p65 subunit, and downregulate p65 in prostate cancer and soft tissue sarcoma cells (Vyasand Singh, 2014). This evidence concerns the gene NFKB1 and prostate cancer.